A problem faced frequently in cardiac surgery is increased postoperative morbidity which develops after the transfusion of blood and blood products. [1, 2] Postoperative complications related to the use of blood and its products are increased infection risk, pulmonary dysfunction, gastrointestinal complications, renal failure, and even increased mortality. [2] [3] [4] [5] Moreover, extraoperative use of blood and its products may cause hemolytic and non-hemolytic transfusion reactions. [6] Therefore, it is worth investigating which complications occurred after the use of specific blood and blood products.
In this study, pre-and postoperative blood urea nitrogen and creatinine values were compared among patients who received blood or blood plus fresh frozen plasma (FFP) when undergoing off-pump or on-pump coronary artery bypass graft (CABG) surgery.
PATIENTS AND METHODS
Between October 2006 and March 2009, a total number of 160 patients (49 females, 111 males; mean age 61.5±10.7 years; range 41 to 82 years) who underwent CABG surgery (88 off-pump, 72 on-pump) in the Department of Cardiovascular Surgery, Atatürk Training and Research Hospital were evaluated retrospectively.
Patients were categorized into off-pump and on-pump groups. Both groups were further divided into three subgroups: blood-only receivers, blood plus FFP receivers and control. Thus, six subgroups were formed, and investigative parameters were compared within these six subgroups.
When considering the postoperative needs, 33 patients received whole blood, 23 patients received whole blood plus FFP, and 32 patients received no blood product in the off-pump group. In the on-pump group, 25 patients received whole blood, 28 patients received whole blood plus FFP and 19 patients received no blood product. Clinical and demographic characteristics of these patients are shown in table 1. th hour were taken into account for the postoperative period. Patients with preoperative creatinine values of more than 2 mg/dl were excluded. Other exclusion criteria included mortality during the preoperative period, congestive heart failure in the preoperative period, preoperative ejection fraction (EF) of less than 35%, the use of preoperative IABP counterpulsation, and emergency operations.
Patients whose condition worsened according to postoperative renal function test results were referred to the Nephrology Department.
Patients were transfused with blood whenever their hematocrit values dropped below 24%. Fresh frozen plasma was used for patients thought to be experiencing coagulopathy and excessive drainage (≥250 ml within first hour) in order to correct the problem and replace fluid loss.
Surgical technique
All patients were operated on under general anesthesia. Median sternotomy was applied, and on-pump or offpump CABG surgery was performed. The left internal mammary artery and great saphenous vein were used as arterial and venous grafts, respectively. Patients that were revascularized on a beating heart were heparinized (100-200 IU/kg), keeping the activated clotting time (ACT) beyond 250 seconds, while patients that underwent conventional surgery were heparinized (300-400 IU/kg), keeping the ACT value beyond 450 seconds. Some patients needed reoperation for bleeding, and some patients received postoperative IABP therapy on an as needed basis.
Statistical analysis
The Statistical Package for Social Sciences (SPSS) for Windows version 15.0 (SPSS inc., Chicago, Illinois, USA) 
RESULTS
Regarding gender distribution, no significant differences among the three subgroups in the on-pump group were noted (p>0.05), but in the off-pump group, blood plus FFP receivers showed a significant difference compared to other subgroups (p<0.05). The mean age of patients was similar in all the subgroups (p>0.05).
In the off-pump group, the preoperative creatinine values showed significant differences among the subgroups (p=0.009). Among the subgroups, blood plus FFP receivers had a higher mean creatinine value than both the blood-only and control groups, which was statistically significant (p<0.05; Table 2 ).
Although the preoperative creatinine values were high in the blood and FFP receiving subgroups of the off-pump group, the postoperative values showed no statistical significance (p>0.05).
The pre-and postoperative BUN values showed no statistical significance among the three subgroups in the off-pump group.
In the off-pump group, when comparing the preand postoperative creatinine values of the blood plus FFP receivers with the control group, no significant difference was noticed. However, the postoperative creatinine values were found to be significantly higher than the preoperative values among the blood receivers and controls (p<0.05; Table 2 ).
The preoperative and postoperative creatinine values among the three subgroups in the on-pump group showed no significant difference (p>0.05).
In the on-pump group, the postoperative mean creatinine values were significantly lower than the preoperative values among the blood plus FFP receivers (p=0.044; Table 2 ), but the pre-and postoperative mean creatinine values did not differ between the blood receivers and controls (p>0.05).
In the on-pump group, the pre-and postoperative BUN values of the three subgroups showed no significant differences.
The amounts of blood or blood plus FFP transfused in all groups are shown in table 3. Correlation analyses concerning the postoperative creatinine values and amount of blood or blood plus FFP transfused in all patients showed no significant correlation (p>0.05).
Comparing the preoperative ejection fractions (EF) of the patients, no statistical significance was detected among the groups (p>0.05; Table 3 ). Moreover, a correlation analysis of the preoperative EF values and postoperative creatinine levels showed no significant correlation (p>0.05). The remaining postoperative data is summarized in table 4.
DISCUSSION
In recent years, although both pharmacological and technical measures have been undertaken to promote a reduction in the use of blood and blood products, blood transfusions with their associated complications are still a serious problem. [7, 8] Many studies stated that using blood products increases the risk for reoperation due to bleeding, gastrointestinal complications, non-cardiac reoperations, prolonged ventilatory support, acute renal failure, pneumonia, and sepsis. [5, [9] [10] [11] [12] Consistent with the literature, both the off-pump and on-pump groups along with the in blood and blood plus FFP subgroups had mean extubation times which were significantly longer compared with the control subgroups. Thakar et al. [13] created a scoring system to predict the risk of acute renal failure in cardiac surgery. According to this system, female gender, a preoperative EF value of less than 35%, congestive heart failure, a history of previous cardiac surgery, preoperative IABP use, diabetes mellitus (DM), emergency surgery, and a preoperative creatinine value of more than 2.1 mg/dl are risk factors for postoperative renal failure. The mean EF of all included patients was greater than 45%, and the mean preoperative creatinine value was less than 1.5 mg/dl. Moreover, patients with preoperative congestive heart failure, preoperative IABP use, and those scheduled to undergo emergent operations were excluded from this study. Twenty-six patients had diabetes as a risk factor for renal failure due to diabetic nephropathy, but the number of diabetic patients was similar in all the groups.
A study by Kuduvalli et al., [14] investigated the effects of blood use in CABG surgery on postoperative mortality and morbidity rates. The incidence of postoperative renal failure was found to be 2.6% among patients receiving blood whereas it was 0.2% among patients who did not. This difference was statistically significant.
In another study by Whitson et al., [5] it was found that using blood products increased the incidence of acute renal failure. Accordingly, the ratio of acute renal failure in the group that did not receive any blood products was 1.8% whereas it was calculated at 8% in the group of blood product recipients, which was statistically significant.
Many other studies have shown that the probability of postoperative renal dysfunction increases with the use of blood in cardiac surgery. [1, [15] [16] [17] [18] [19] In our study, although there wasn't any significant difference between preoperative and postoperative serum creatinine values in the on-pump group blood-only subgroup (consistent with the literature), postoperative mean serum creatinine values were significantly higher than the preoperative values in the off-pump group blood-only subgroup.
In another study conducted by Godet et al., [19] risk factors for acute renal failure were investigated among patients undergoing thoracic and thoracoabdominal aortic surgery. According to the results of this study, an average of seven units of packed red blood cells was used in the group which was free of acute renal failure whereas 11 units were used in the group which developed it. This difference was statistically significant. A mean of 2.1 L of FFP was used in the group which was free of acute renal failure whereas, in those where it developed, 2.9 L of FFP was used. This difference was statistically significant as well. However, in our study, the postoperative mean serum creatinine values were not higher than the preoperative values of blood plus FFP subgroups of both the on-pump and off-pump groups. In conclusion, blood and its products are widely used in cardiac surgery. One of the many complications of blood and blood product usage is the development of postoperative renal failure. Based on our study, we think that the use of FFP is safer than blood in terms of renal function impairment.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Funding

